Emergency use authorization for Baricitinib

Published
5th May, 2021

“The Emergency Use Authorization (EUA) of a drug without Phase 4 clinical trials allows to expand the scope of trials outside laboratory among the public.” Critically comment highlighting the ethical concerns arising out of large vaccination drives administering EUA drugs.

PIL against GNCTD (Amendment) Act, 2021

Oil import from OPEC falls to two decades low

Mutation in coronavirus

Used cooking oil (UCO) biodiesel